Hindustan Bio Sciences quarterly results and financials

Hindustan Bio Sciences (BSE 532041)₹6.70+3.08%(9 Nov 2026 close)Software Products

Key facts

In the Jun 2026 quarter (standalone), Hindustan Bio Sciences reported sales of ₹0 Cr, down 100.0% from Jun 2025, and net profit of −₹0.12 Cr, down 700.0% year on year. For the year to Mar 2026, sales were ₹0.73 Cr and net profit −₹0.09 Cr.

Sales (Jun 2026): ₹0 Cr
Net profit (Jun 2026): −₹0.12 Cr
Sales (FY Mar 2026): ₹0.73 Cr
Net profit (FY Mar 2026): −₹0.09 Cr
EPS (Jun 2026): ₹−0.12
Borrowings (Mar 2026): ₹2.35 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Hindustan Bio Sciences quarterly results

₹ crore unless stated; each column is a quarter.

Hindustan Bio Sciences Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	0.31	0.31	0.38	0.40	0.40	0.00	0.37	0.31	0.00	0.37	0.00	0.00
Expenses	0.25	0.25	0.34	0.33	0.33	0.03	0.27	0.31	0.05	0.30	0.10	0.10
Operating Profit	0.07	0.07	0.05	0.08	0.08	−0.05	0.11	0.00	−0.07	0.08	−0.12	−0.12
OPM %	18.8%	18.8%	10.3%	17.1%	17.1%	—	26.4%	0.0%	—	18.5%	—	—
Other Income	0.02	0.02	0.00	0.00	0.00	0.00	0.02	0.00	0.00	0.01	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	0.06	0.06	0.03	0.07	0.07	−0.03	0.10	0.00	−0.04	0.07	−0.10	−0.10
Tax %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net Profit	0.08	0.08	0.05	0.09	0.09	−0.05	0.12	0.02	−0.07	0.09	−0.13	−0.12
EPS (Rs)	0.08	0.08	0.05	0.09	0.09	−0.05	0.12	0.02	−0.07	0.09	−0.13	−0.12

Hindustan Bio Sciences profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Hindustan Bio Sciences Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	1.25	1.00	1.02	3.55	1.93	1.02	0.42	0.91	1.04	0.80	0.73	0.37
Expenses	1.37	1.47	3.37	3.42	1.79	1.96	0.93	0.94	0.98	0.70	0.79	0.55
Operating Profit	−0.13	−0.48	−2.36	0.14	0.15	−0.95	−0.52	−0.04	0.07	0.11	−0.07	−0.23
OPM %	−9.5%	−46.5%	−228.1%	3.7%	7.3%	−91.2%	−118.6%	−3.2%	5.8%	12.4%	−8.1%	−62.2%
Other Income	−1.91	0.00	0.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01
Interest	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00
Profit before tax	−2.07	−0.48	−2.26	0.10	0.11	−0.95	−0.50	−0.03	0.04	0.09	−0.07	−0.17
Tax %	0.0%	0.0%	0.0%	0.0%	33.3%	−2.1%	0.0%	0.0%	0.0%	0.0%	0.0%	—
Exceptional items	−1.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
Net Profit	−2.10	−0.50	−2.29	0.12	0.09	−0.95	−0.53	−0.05	0.07	0.11	−0.09	−0.23
EPS (Rs)	−2.05	−0.49	−2.23	0.12	0.09	−0.93	−0.52	−0.05	0.07	0.11	−0.09	−0.23
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Hindustan Bio Sciences balance sheet

₹ crore, at each year end.

Hindustan Bio Sciences Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	10.28	10.27	10.27	10.27	10.27	10.27	10.27	10.27	2.06	2.06	2.06	2.06
Reserves	−3.34	−5.44	−5.93	−8.20	−8.10	−8.02	−8.95	−9.46	−1.30	−1.25	−1.15	−1.22
Borrowings	0.96	0.93	1.29	1.56	3.36	2.59	1.85	2.16	2.46	2.56	2.51	2.35
Other Liabilities	0.18	0.14	0.26	0.10	0.12	0.73	0.33	0.03	0.09	0.02	0.02	0.03
Total Liabilities	8.08	5.90	5.89	3.73	5.65	5.57	3.50	3.00	3.31	3.39	3.44	3.22
Fixed Assets	0.09	0.08	0.07	0.07	0.07	0.06	0.05	0.05	0.04	0.04	0.04	0.02
CWIP	1.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	6.06	5.82	5.82	3.66	5.58	5.51	3.45	2.95	3.27	3.35	3.40	3.20
Inventories	0.10	0.00	0.00	0.09	0.12	0.35	0.00	0.00	0.00	0.00	0.00	0.00
Trade receivables	0.33	0.48	0.48	0.33	1.68	1.37	0.63	0.15	0.46	0.45	0.45	0.06
Cash & equivalents	0.21	0.04	0.05	0.03	0.19	0.21	0.03	0.02	0.02	0.05	0.02	0.14
Total Assets	8.08	5.90	5.89	3.73	5.65	5.57	3.50	3.00	3.31	3.39	3.44	3.22

Hindustan Bio Sciences cash flow

₹ crore, for each year.

Hindustan Bio Sciences Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	−0.26	0.45	−0.15	−0.22	−1.31	0.81	0.74	−0.33	−0.04	−1.40	0.02	0.27
Cash from investing activity	0.00	0.00	0.00	0.00	−0.02	0.00	0.00	0.00	0.00	0.00	0.00	−0.02
Cash from financing activity	0.29	−0.62	0.17	0.20	1.49	−0.80	−0.92	0.33	0.04	1.42	−0.04	−0.15
Net cash flow	0.04	−0.18	0.02	−0.03	0.18	0.02	−0.19	−0.02	0.00	0.04	−0.03	0.13
Capex	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.41
Free cash flow	−0.26	0.45	−0.15	−0.22	−1.32	0.81	0.74	−0.33	−0.04	−1.40	0.02	0.26
CFO / OP %	22.1%	−383.0%	34.0%	10.1%	−1,014.9%	600.1%	−78.0%	67.1%	167.1%	−2,350.0%	30.0%	−466.9%

Hindustan Bio Sciences ratios

Working-capital days and returns, by year.

Hindustan Bio Sciences Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	155	135	169	112	170	255	219	118	178	152	197	24
Inventory days	24	0	0	50	13	94	0	0	0	0	0	0
Days payable	39	—	—	45	8	185	—	—	—	—	—	—
Cash conversion cycle	142	136	170	120	178	166	220	119	179	153	198	25
Working capital days	113	−63	−191	−169	86	88	−148	−500	−225	314	443	307
ROCE %	−16.4%	−1.9%	−8.5%	−49.2%	2.6%	2.5%	−23.8%	−16.7%	−1.3%	1.5%	2.9%	−2.4%

Hindustan Bio Sciences: frequently asked questions

What are the latest quarterly results of Hindustan Bio Sciences?

For the Jun 2026 quarter, Hindustan Bio Sciences reported sales of ₹0 Cr, down 100.0% year on year and net profit of −₹0.12 Cr, down 700.0% year on year.

What is the annual revenue of Hindustan Bio Sciences?

Hindustan Bio Sciences' sales for the year to Mar 2026 were ₹0.73 Cr; over the last twelve months they were ₹0.37 Cr.

What is the net profit of Hindustan Bio Sciences?

Net profit for the year to Mar 2026 was −₹0.09 Cr, and −₹0.23 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.23.

How much debt does Hindustan Bio Sciences have?

Hindustan Bio Sciences reported borrowings of ₹2.35 Cr at Mar 2026, against cash and equivalents of ₹0.14 Cr.

What is the free cash flow of Hindustan Bio Sciences?

Cash from operations was ₹0.27 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.26 Cr.

Loading…